Phospho-GAP43 (Ser41) Antibody

What is GAP-43 and why is its phosphorylation at Ser-41 important?

GAP-43 (also known as neuromodulin) is a neuron-specific protein that plays a crucial role in axonal growth and regeneration. It's a major component of neuronal growth cones that form at the tips of elongating axons . Phosphorylation at Ser-41 by PKC is a critical regulatory mechanism that:

• Modulates GAP-43's interaction with actin, affecting growth cone motility

• Is required for plasma membrane association of palmitoylated GAP-43

• Affects the association with the membrane skeleton

• Facilitates axon guidance and outgrowth

• Influences neurotransmission and synaptic plasticity

• Abolishes calmodulin binding to GAP-43

This phosphorylation acts as a molecular switch that regulates GAP-43's subcellular localization and function during neuronal development and plasticity.

What applications can Phospho-GAP43 (Ser41) Antibody be used for?

Phospho-GAP43 (Ser41) Antibody is versatile and can be used in several research applications:

These applications collectively enable researchers to investigate GAP-43's role in axonal growth, regeneration, and synaptic plasticity, with a specific focus on the phosphorylated form at Ser-41 .

What species reactivity does the Phospho-GAP43 (Ser41) Antibody typically show?

Most commercially available Phospho-GAP43 (Ser41) antibodies show broad cross-species reactivity due to the high conservation of the GAP-43 sequence around Ser-41:

• Human

• Mouse

• Rat

• Bovine

• Canine/Dog

• Chicken

• Non-human primates/Monkey

• Xenopus

• Zebrafish

How should Phospho-GAP43 (Ser41) Antibody be stored to maintain its efficacy?

Optimal storage conditions for Phospho-GAP43 (Ser41) Antibody typically include:

• Long-term storage: -20°C or -80°C

• Aliquoting: Divide into smaller working volumes (10-30 μL) upon arrival to avoid freeze-thaw cycles

• Working aliquot: Can be kept at 4°C for short-term use

• Buffer composition: Often supplied in buffer containing:

  • 50% glycerol (prevents freezing at -20°C)

  • 0.5-1% BSA (prevents adsorption to tube)

  • 0.02-0.09% sodium azide (preservative)

  • 10 mM HEPES, pH 7.5, 150 mM NaCl

Under these conditions, the antibody typically remains stable for at least 12 months . Always check the manufacturer's specific recommendations, as formulations may vary.

How can I validate the specificity of my Phospho-GAP43 (Ser41) Antibody?

Validating the specificity of Phospho-GAP43 (Ser41) Antibody is crucial for reliable results. Here are methodological approaches:

• Phosphatase Treatment: Treat a portion of your sample with lambda phosphatase before immunoblotting. The signal should be eliminated or significantly reduced, confirming phospho-specificity .

• Competing Peptides: Pre-incubate the antibody with the phosphopeptide used as the immunogen. This should block specific binding and abolish the signal. For comparison, also perform a control with the corresponding non-phosphorylated peptide .

• Phosphomimetic and Phospho-null Mutants: Use cells expressing GAP-43 with mutations at Ser-41 - either a phosphomimetic (S41D) or phospho-null (S41A) variant. The antibody should recognize the wild-type protein after PKC activation but not the S41A mutant .

• PKC Activators/Inhibitors: Treat samples with PKC activators (e.g., phorbol esters) or inhibitors to alter phosphorylation levels. The antibody signal should change accordingly .

• Western Blot Analysis: The antibody typically detects a ~50 kDa band corresponding to phosphorylated GAP-43. In some tissues, it may also recognize higher molecular weight proteins, possibly GAP-43 aggregates or oligomers .

These validation steps ensure that the observed signal is specific to phosphorylated GAP-43 at Ser-41.

How can I study the interplay between phosphorylation and palmitoylation in GAP-43 sorting?

The interplay between phosphorylation and palmitoylation is critical for GAP-43 sorting and function. Here's how to study this using Phospho-GAP43 (Ser41) Antibody:

• Subcellular Fractionation: Use magnetic sphere separation of surface-biotinylated cells to enrich for plasma membranes and associated proteins. Compare distribution of total GAP-43 versus phosphorylated GAP-43 between membrane and cytosolic fractions .

• Mutant Analysis: Generate constructs with mutations affecting either phosphorylation (S41A, S41D) or palmitoylation (C3,4S) or both. The search results indicate:

  • Palmitoylation-deficient GAP-43 (C3,4S) is almost completely cytosolic, regardless of phosphorylation status

  • Phosphomimicking GAP-43 (S41D) shows significantly higher peripheral enrichment than wild-type

  • Phospho-blocking GAP-43 (S41A) shows lower peripheral enrichment

• Palmitoylation Assay: Use [³H]palmitate labeling combined with antibody detection to assess if phosphorylation affects palmitoylation levels. Research indicates that phosphomimicking GAP-43 (S41D) exhibits increased palmitoylation .

• Microscopy Analysis: Use immunofluorescence with Phospho-GAP43 (Ser41) Antibody to visualize the subcellular distribution of phosphorylated GAP-43 in relation to membrane markers .

This approach can reveal how these two post-translational modifications cooperatively regulate GAP-43 targeting, where "palmitoylation tags GAP43 for global sorting by inducing piggybacking on exocytic vesicles, whereas phosphorylation locally regulates plasma membrane targeting of palmitoylated GAP43" .

What role does GAP-43 phosphorylation play in synaptic plasticity?

GAP-43 phosphorylation at Ser-41 plays a significant role in synaptic plasticity. To investigate this using Phospho-GAP43 (Ser41) Antibody:

• Molecular Mechanisms: Phosphorylated GAP-43:

  • Interacts with the presynaptic vesicle fusion complex (Syntaxin, SNAP-25, VAMP)

  • Promotes actin polymerization and stabilization

  • May affect neurotransmitter release during LTP (Long-Term Potentiation)

• Experimental Approaches:

  • Synaptosome Isolation: Prepare synaptosomes from brain tissue and analyze phosphorylated GAP-43 levels using the antibody

  • FM Dye Experiments: Combine FM dye (which traces vesicle cycling) with immunocytochemistry using Phospho-GAP43 (Ser41) Antibody to correlate phosphorylation with presynaptic release

  • PKC Manipulation: Use PKC activators/inhibitors during plasticity induction, then assess effects on both synaptic potentiation and GAP-43 phosphorylation

  • Phosphomimetic Expression: Express phosphomimetic (S41D) or phospho-null (S41A) GAP-43 mutants in neurons to assess effects on synaptic transmission

• In Vivo Correlates: Analyze brain regions after learning tasks for changes in GAP-43 phosphorylation using the antibody .

These approaches can help establish causal relationships between GAP-43 phosphorylation and functional changes in synaptic efficacy that underlie learning and memory.

How does phosphorylation at Ser-41 affect GAP-43's interaction with calmodulin?

The relationship between GAP-43 phosphorylation at Ser-41 and calmodulin binding is important to understand:

• Structural Basis: Ser-41 is located within an IQ domain that serves as a binding site for EF-hand proteins such as calmodulin .

• Regulatory Mechanism: Phosphorylation by PKC at Ser-41 abolishes calmodulin binding to GAP-43 . This provides a switch mechanism where calcium signals can lead to PKC activation, which phosphorylates GAP-43, thereby releasing calmodulin.

• Experimental Approaches:

  • Binding Assays: Use GST-GAP-43 fusion proteins (wild-type, S41A, S41D) to assess calmodulin binding in vitro

  • Co-immunoprecipitation: Immunoprecipitate with either Phospho-GAP43 (Ser41) Antibody or calmodulin antibody, then probe for the other protein

  • Calcium Dependence: Examine binding in buffers with or without calcium (noted in search result that some experiments were performed with CaCl₂ omitted from buffers)

• Functional Consequences: This phosphorylation-dependent regulation of calmodulin binding affects:

  • GAP-43's interaction with the actin cytoskeleton

  • Membrane association

  • Growth cone motility and neurite outgrowth

Understanding this mechanism helps explain how calcium signaling regulates GAP-43 function through the interplay of calmodulin binding and phosphorylation.

What controls should I include when using Phospho-GAP43 (Ser41) Antibody?

Robust controls are essential when working with phospho-specific antibodies:

Positive Controls:

• Brain tissue or neuronal cultures known to express phosphorylated GAP-43

• Samples treated with PKC activators to increase phosphorylation at Ser-41

Negative Controls:

• Lambda phosphatase-treated samples to remove phosphorylation

• Samples treated with PKC inhibitors to reduce phosphorylation

• Non-neuronal tissues with minimal GAP-43 expression

Specificity Controls:

• Competition with phosphopeptide immunogen (should block signal)

• Competition with non-phosphopeptide (should not block signal)

• Secondary antibody-only control

Mutation Controls:

• When possible, include GAP-43 phosphomimetic (S41D) and phospho-null (S41A) mutants

Quantification Controls:

• Loading controls for Western blots

• Total GAP-43 antibody staining on parallel samples for normalization

These controls help distinguish true phospho-GAP-43 signal from artifacts and ensure quantitative comparisons are valid.

How can I design an experiment to study the effect of various stimuli on GAP-43 phosphorylation?

When designing experiments to study stimuli-induced GAP-43 phosphorylation:

• Cell/Tissue Selection:

  • Primary neurons (cortical, hippocampal, or DRG neurons)

  • Brain slices (for more intact circuitry)

  • In vivo models (for physiological relevance)

• Stimulus Selection:

  • Neurotrophic factors (BDNF, NGF)

  • Depolarizing stimuli (KCl, electrical stimulation)

  • Guidance cues (netrins, semaphorins)

  • Injury models (axotomy, crush injury)

• Time Course Analysis:

  • Include multiple time points (e.g., 5min, 15min, 30min, 1h, 3h, 24h)

  • This reveals both acute and sustained phosphorylation changes

• Signaling Pathway Analysis:

  • Use specific inhibitors to dissect upstream pathways

  • Include PKC inhibitors (e.g., GF109203X)

  • Test calcium chelators (considering the calcium dependence noted in )

• Detection Methods:

  • Western blotting with Phospho-GAP43 (Ser41) Antibody (typical dilution 1:1000)

  • Immunocytochemistry (dilution range 1:200-1:1000)

  • Compare with total GAP-43 levels using a pan-GAP-43 antibody

• Sample Protocol Outline:

  • Culture neurons or prepare tissue samples

  • Apply selected stimulus (and inhibitors where applicable)

  • Harvest samples at predetermined time points

  • Process for Western blot or fix for immunocytochemistry

  • Include phosphatase inhibitors in all buffers

  • Probe with Phospho-GAP43 (Ser41) Antibody

  • Normalize to total GAP-43 levels

  • Correlate with functional measurements (growth cone dynamics, neurite extension)

This systematic approach allows for comprehensive analysis of how various stimuli affect GAP-43 phosphorylation and its downstream functional consequences in neuronal development and plasticity .

What challenges might I encounter when using Phospho-GAP43 (Ser41) Antibody for quantitative analysis?

Quantitative analysis of GAP-43 phosphorylation presents several methodological challenges:

• Phosphorylation Lability:

  • Phosphorylation is highly dynamic and can be lost during sample preparation

  • Include phosphatase inhibitors (e.g., sodium vanadate, β-glycerophosphate) in all buffers

  • Keep samples cold throughout processing

• Band Pattern Complexity:

  • In some tissues, the antibody may recognize higher molecular weight proteins in addition to the ~50 kDa GAP-43 band

  • These may be GAP-43 aggregates or oligomers and should be accounted for in quantification

• Normalization Strategy:

  • Normalize phospho-GAP-43 signal to total GAP-43 levels using a pan-GAP-43 antibody

  • Include loading controls for general protein content

• Batch-to-batch Variability:

  • Polyclonal antibodies can show batch-to-batch variation

  • Include consistent positive controls across experiments

• PTM Interplay:

  • Phosphorylation at Ser-41 may be influenced by other modifications like palmitoylation

  • Consider the effects of these interacting modifications in your experimental design

• Temporal Dynamics:

  • GAP-43 phosphorylation can change rapidly in response to stimuli

  • Design time-course experiments with appropriate short intervals

  • Compare with other phosphorylation sites (e.g., T172) which may have different temporal dynamics

Addressing these challenges with appropriate controls and normalization can help ensure reliable quantification of GAP-43 phosphorylation levels.

How does GAP-43 phosphorylation compare with other post-translational modifications in neuronal development?

GAP-43 undergoes multiple post-translational modifications that work in concert:

• Phosphorylation vs. Palmitoylation:

  • Palmitoylation at Cys-3 and Cys-4 is crucial for membrane binding

  • Phosphorylation at Ser-41 affects plasma membrane association of palmitoylated GAP-43

  • These modifications exhibit complex interplay: "palmitoylation tags GAP43 for global sorting by inducing piggybacking on exocytic vesicles, whereas phosphorylation locally regulates plasma membrane targeting of palmitoylated GAP43"

• Multiple Phosphorylation Sites:

  • GAP-43 can be phosphorylated at multiple sites beyond Ser-41

  • Recently identified phosphorylation sites include S96 and T172

  • Different phosphorylation sites may have distinct temporal dynamics during development

• Comparison with BASP1:

  • BASP1 (Brain Acid Soluble Protein 1) shares functional similarities with GAP-43

  • Both undergo Ca²⁺-dependent phosphorylation by PKC (Serine-41 in GAP-43; Serine-6 in BASP1)

  • Both can be dephosphorylated by calcineurin

  • Phosphorylation abolishes calmodulin binding to both proteins

• Experimental Approaches:

  • Use antibodies specific to different post-translational modifications

  • Compare the distribution and timing of different modifications during development

  • Use mutation analysis to assess the relative importance of each modification

Understanding the orchestration of these various modifications helps explain how GAP-43 function is regulated throughout neuronal development and regeneration.

What are the latest findings on GAP-43 phosphorylation in neurological disorders?

While the search results don't provide extensive information on this topic, they do mention some connections between GAP-43 and neurological disorders:

• Alzheimer's Disease:

  • Aberrant GAP-43 expression can be seen in patients diagnosed with Alzheimer's Disease

  • Phospho-GAP43 (Ser41) Antibody could be used to investigate whether phosphorylation status is altered in disease models

• Schizophrenia:

  • Aberrant GAP-43 expression has been noted in patients diagnosed with schizophrenia

  • Changes in GAP-43 phosphorylation might contribute to synaptic dysfunction in this disorder

• Neural Injury and Regeneration:

  • GAP-43 is strongly related to axon growth and regeneration

  • Phosphorylation at Ser-41 facilitates axon guidance and outgrowth

  • Phospho-GAP43 (Ser41) Antibody could be used as a molecular marker to monitor regenerative processes after injury

• Research Applications:

  • Compare phosphorylated GAP-43 levels in normal vs. diseased tissue

  • Examine the effect of therapeutic interventions on GAP-43 phosphorylation

  • Investigate whether modulating GAP-43 phosphorylation could have therapeutic potential

This remains an area ripe for further investigation, as changes in phosphorylation of key neuronal proteins like GAP-43 may contribute to pathophysiology or represent adaptive responses in various neurological conditions.